Specific Use-Result Surveillance of Spiriva Respimat in Asthmatics (Patients With Mild and Moderate Persistent Asthma)
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2018
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 29 Nov 2018 Status changed from active, no longer recruiting to completed.
- 04 Oct 2018 Planned End Date changed from 30 Sep 2018 to 17 Nov 2018.
- 04 Oct 2018 Planned primary completion date changed from 30 Sep 2018 to 17 Nov 2018.